MarketKingdoms › Financial statements › CAHCardinal Health Inc. (CAH) financial statements: income statement, balance sheet and cash flow
Cardinal Health Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Jun 30, 2026 · FY), Cardinal Health Inc. reported revenue of $254.2B (+14.2% year on year) and net income of $1.7B (+9.8% year on year).
Income statement Cardinal Health Inc. income statement, fiscal years
Line item Jun 30, 2026 · FY Jun 30, 2025 · FY Jun 30, 2024 · FY Jun 30, 2023 · FY
Revenue $254.2B $222.6B $226.8B $205.0B Cost of products sold $244.5B $214.4B $219.4B $198.1B Gross margin $9.8B $8.2B $7.4B $6.9B Distribution, selling, general, and administrative expenses $6.1B $5.4B $5.0B $4.8B Restructuring and employee severance $106.0M $88.0M $175.0M $95.0M Amortization and other acquisition-related costs $469.0M $464.0M $284.0M $285.0M Impairments and (gain)/loss on disposal of assets, net $177.0M $18.0M $634.0M $1.3B Litigation (recoveries)/charges, net ($10.0M) ($185.0M) $78.0M ($302.0M) Operating earnings $2.6B $2.3B $1.2B $727.0M Other (income)/expense, net ($31.0M) ($41.0M) ($9.0M) ($4.0M) Interest expense, net $348.0M $215.0M $51.0M $93.0M Equity Method Investment, Other-than-Temporary Impairment $122.0M — — — Earnings before income taxes $2.2B $2.1B $1.2B $638.0M Income Tax Expense (Benefit) $469.0M $532.0M $348.0M $376.0M Net earnings $1.7B $1.6B $853.0M $262.0M Less: Net (earnings)/loss attributable to noncontrolling interests $9.0M ($8.0M) ($1.0M) ($1.0M) Net earnings attributable to Cardinal Health, Inc. $1.7B $1.6B $852.0M $261.0M Basic (in dollars per share) $7.27 $6.48 $3.48 $1.00 Diluted (in dollars per share) $7.23 $6.45 $3.45 $1.00 Basic (in shares) 236.0M 241.0M 245.0M 261.0M Diluted (in shares) 237.0M 242.0M 247.0M 262.0M
Cardinal Health Inc. income statement, quarters
Line item Mar 31, 2026 · Q3 Dec 31, 2025 · Q2 Sep 30, 2025 · Q1 Mar 31, 2025 · Q3
Revenue $60.9B $65.6B $64.0B $54.9B Cost of products sold $58.4B $63.2B $61.7B $52.8B Gross margin $2.5B $2.4B $2.3B $2.1B Distribution, selling, general and administrative expenses $1.5B $1.5B $1.5B $1.3B Restructuring and employee severance $25.0M $21.0M $20.0M $28.0M Amortization and other acquisition-related costs $114.0M $130.0M $104.0M $152.0M Impairments and (gain)/loss on disposal of assets, net $185.0M ($14.0M) $2.0M ($17.0M) Litigation (recoveries)/charges, net $11.0M ($18.0M) $0 ($105.0M) Operating earnings $509.0M $707.0M $668.0M $730.0M Other (income)/expense, net $16.0M ($11.0M) ($10.0M) ($9.0M) Interest Expense, Nonoperating $101.0M — — — Earnings/(loss) before income taxes $392.0M $630.0M $598.0M $665.0M Provision for income taxes $12.0M $159.0M $144.0M $157.0M Net earnings/(loss) $380.0M $471.0M $454.0M $508.0M Less: Net earnings attributable to noncontrolling interests $19.0M ($4.0M) ($4.0M) ($2.0M) Net earnings attributable to Cardinal Health, Inc. $399.0M $467.0M $450.0M $506.0M Basic (in shares) 1.69 1.98 1.89 2.11 Diluted (in shares) 1.69 1.97 1.88 2.1 Basic (in shares) 235.0M 236.0M 238.0M 240.0M Diluted (in shares) 236.0M 237.0M 239.0M 241.0M Cash dividends declared per common share $0.51 $0.51 $0.51 $0.51 Acquisition-related cash and share-based compensation costs $112.0M $67.0M $64.0M $20.0M
Balance sheet Cardinal Health Inc. balance sheet, fiscal years
Line item Jun 30, 2026 · FY Jun 30, 2025 · FY Jun 30, 2024 · FY Jun 30, 2023 · FY
Cash and equivalents $4.9B $3.9B $5.1B $4.0B Trade receivables, net $13.8B $13.2B $12.1B $11.3B Inventories, net $17.3B $16.8B $15.0B $15.9B Prepaid expenses and other $2.8B $2.4B $2.7B $2.4B Assets held for sale $21.0M $12.0M $47.0M $144.0M Total current assets $38.8B $36.4B $34.9B $33.8B Property and equipment, net $3.0B $2.9B $2.5B $2.5B Goodwill and other intangibles, net $13.6B $12.2B $6.5B $6.1B Other assets $1.9B $1.7B $1.3B $1.0B Assets, Total $57.3B $53.1B $45.1B $43.4B Accounts payable $38.3B $34.7B $31.8B $29.8B Current portion of long-term obligations and other short-term borrowings $1.9B $550.0M $434.0M $792.0M Other accrued liabilities $3.7B $3.6B $3.4B $3.1B Total current liabilities $43.9B $38.9B $35.6B $33.7B Long-term obligations, less current portion $7.0B $8.0B $4.7B $3.9B Deferred income taxes and other liabilities $9.1B $8.9B $8.0B $8.7B Authorized—500 thousand shares, Issued—none 0 0 0 0 Authorized—755 million shares, Issued— 271 million shares at June 30, 2026 and 2025 2.9B 3.0B 2.9B 2.7B Retained earnings $2.0B $783.0M ($286.0M) ($534.0M) Common shares in treasury, at cost: 38 million shares and 32 million shares at June 30, 2026 and 2025, respectively -7.6B -6.4B -5.7B -4.9B Accumulated other comprehensive loss ($165.0M) ($155.0M) ($167.0M) ($151.0M) Total Cardinal Health, Inc. shareholders' deficit ($2.9B) ($2.8B) ($3.2B) ($2.9B) Noncontrolling interests $159.0M $147.0M $1.0M $1.0M Total shareholders’ deficit ($2.7B) ($2.6B) ($3.2B) ($2.9B) Total liabilities and shareholders’ deficit $57.3B $53.1B $45.1B $43.4B
Cardinal Health Inc. balance sheet, quarters
Line item Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Mar 31, 2025
Cash and equivalents $3.9B $2.8B $4.6B $3.3B Trade receivables, net $13.6B $13.7B $13.8B $12.7B Inventories, net $18.0B $20.1B $17.6B $16.2B Prepaid expenses and other $2.5B $2.7B $2.6B $2.4B Assets held for sale $0 $0 $13.0M $47.0M Total current assets $38.1B $39.2B $38.5B $34.6B Property and equipment, net $2.9B $2.9B $2.8B $2.7B Goodwill and other intangibles, net $13.7B $14.0B $12.1B $11.0B Other assets $2.0B $2.0B $1.8B $1.6B Total assets $56.7B $58.1B $55.2B $49.9B Accounts payable $37.8B $39.0B $36.9B $32.8B Current portion of long-term obligations and other short-term borrowings $671.0M $680.0M $52.0M $543.0M Other accrued liabilities $3.5B $3.6B $3.4B $3.3B Total current liabilities $42.0B $43.3B $40.3B $36.7B Long-term obligations, less current portion $8.2B $8.3B $9.0B $7.1B Deferred income taxes and other liabilities $9.1B $9.1B $8.7B $8.0B Authorized—500 thousand shares, Issued—none 0 0 0 0 Authorized—755 million shares, Issued—271 million shares at March 31, 2026 and June 30, 2025 2.8B 2.8B 2.7B 2.9B Retained earnings $1.7B $1.5B $1.1B $664.0M Common shares in treasury, at cost: 36 million shares and 32 million shares at March 31, 2026 and June 30, 2025, respectively -7.2B -7.0B -6.6B -6.4B Accumulated other comprehensive loss ($161.0M) ($153.0M) ($159.0M) ($176.0M) Total Cardinal Health, Inc. shareholders' deficit ($2.8B) ($2.9B) ($2.9B) ($2.9B) Noncontrolling interests $160.0M $184.0M $148.0M $1.1B Total shareholders’ deficit ($2.7B) ($2.7B) ($2.7B) ($1.9B) Total liabilities and shareholders’ deficit $56.7B $58.1B $55.2B $49.9B Preferred shares, authorized 500.0K 500.0K 500.0K 500.0K Preferred shares, issued 0 0 0 0 Common shares, authorized 755.0M 755.0M 755.0M 755.0M Common shares, issued 271.0M 271.0M 271.0M 271.0M Common shares in treasury 36.0M 35.0M 33.0M 32.0M
Cash flow statement Cardinal Health Inc. cash flow statement, fiscal years
Line item Jun 30, 2026 · FY Jun 30, 2025 · FY Jun 30, 2024 · FY Jun 30, 2023 · FY
Net earnings $1.7B $1.6B $853.0M $262.0M Depreciation and amortization $956.0M $790.0M $710.0M $692.0M Impairments and (gain)/loss on sale of other investments, net $21.0M $3.0M $2.0M $7.0M Equity Method Investment, Other-than-Temporary Impairment $122.0M — — — Impairments and (gain)/loss on disposal of assets, net $177.0M $18.0M $634.0M $1.3B Share-based compensation $367.0M $244.0M $121.0M $96.0M Provision for/(benefit from) deferred income taxes $91.0M $243.0M ($104.0M) ($31.0M) Provision for bad debts $74.0M $53.0M $36.0M $99.0M Increase in trade receivables ($408.0M) ($833.0M) ($996.0M) ($947.0M) (Increase)/decrease in inventories ($488.0M) ($1.8B) $1.1B ($340.0M) Increase in accounts payable $3.5B $2.7B $1.8B $2.7B Repurchases of liability-classified units ($45.0M) — — — Other accrued liabilities and operating items, net ($861.0M) ($606.0M) ($433.0M) ($967.0M) Net cash provided by operating activities $5.2B $2.4B $3.8B $2.8B Acquisition of subsidiaries, net of cash acquired ($2.0B) ($5.3B) ($1.2B) ($10.0M) Additions to property and equipment ($649.0M) ($547.0M) ($511.0M) ($481.0M) Proceeds from disposal of property and equipment $31.0M — $12.0M $12.0M Proceeds from investments $41.0M — $1.0M $3.0M Payments for (Proceeds from) Hedge, Investing Activities ($13.0M) — — — Purchase of short-term time deposits $0 $0 ($550.0M) — Proceeds from short-term investment in time deposit $0 $200.0M $350.0M — Other investing items, net ($3.0M) $2.0M — — Net cash used in investing activities ($2.6B) ($5.6B) ($1.8B) ($454.0M) Proceeds from long-term obligations, net of issuance costs $990.0M $3.7B $1.1B — Purchase of noncontrolling interests $11.0M $12.0M $0 $3.0M Reduction of long-term obligations ($653.0M) ($445.0M) ($783.0M) ($579.0M) Net tax proceeds/(withholding) from share-based compensation ($79.0M) ($13.0M) $46.0M $56.0M Dividends on common shares -491.0M -494.0M -499.0M -525.0M Purchase of treasury shares -1.4B -765.0M -750.0M -2.0B Net cash provided by/(used in) financing activities ($1.6B) $1.9B ($847.0M) ($3.1B) Effect of exchange rates changes on cash and equivalents ($6.0M) ($3.0M) ($9.0M) ($8.0M) Net increase/(decrease) in cash and equivalents $982.0M ($1.3B) $1.1B ($674.0M) Cash and equivalents at beginning of period $3.9B $5.1B $4.1B $4.7B Cash and equivalents at end of period $4.9B $3.9B $5.1B $4.0B Cash payments for interest $406.0M $315.0M $214.0M $203.0M Net cash payments for income taxes $338.0M $444.0M $191.0M $156.0M
Cardinal Health Inc. cash flow statement, quarters
Line item Mar 31, 2026 · YTD Dec 31, 2025 · YTD Sep 30, 2025 · Q1 Mar 31, 2025 · YTD
Net earnings/(loss) $1.3B $925.0M $454.0M $1.3B Depreciation and amortization $715.0M $467.0M $233.0M $581.0M Impairments and (gain)/loss on disposal of assets, net $173.0M ($12.0M) $2.0M ($15.0M) Impairments and loss on sale of other investments ($20.0M) ($5.0M) — ($2.0M) Share-based compensation $309.0M $180.0M $93.0M $91.0M Provision for bad debts $47.0M $27.0M $13.0M $41.0M Increase in trade receivables ($215.0M) ($198.0M) ($539.0M) ($367.0M) Increase in inventories ($1.2B) ($3.3B) ($736.0M) ($1.2B) Increase in accounts payable $3.0B $4.2B $2.1B $954.0M Repurchases of liability-classified units ($27.0M) ($22.0M) — — Other accrued liabilities and operating items, net ($673.0M) ($610.0M) ($699.0M) ($534.0M) Net cash provided by operating activities $3.5B $1.7B $973.0M $870.0M Acquisition of subsidiaries, net of cash acquired $2.0B $1.9B ($41.0M) $3.9B Additions to property and equipment ($385.0M) ($239.0M) ($108.0M) ($315.0M) Proceeds from disposal of property and equipment $31.0M $31.0M — $3.0M Proceeds from short-term investment in time deposit $0 $0 — $200.0M Net cash used in investing activities ($2.3B) ($2.1B) ($142.0M) ($4.0B) Proceeds from long-term obligations, net of issuance costs $991.0M $989.0M — $2.9B Reduction of long-term obligations ($637.0M) ($524.0M) ($512.0M) ($434.0M) Net tax withholding from share-based compensation ($79.0M) ($81.0M) ($80.0M) ($12.0M) Dividends on common shares -371.0M -251.0M -129.0M -374.0M Purchase of treasury shares, net -1.0B -758.0M -375.0M -765.0M Net cash provided by/(used in) financing activities ($1.1B) ($629.0M) ($110.0M) $1.3B Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation ($4.0M) ($5.0M) ($2.0M) $1.0M Net increase/(decrease) in cash and equivalents $63.0M ($1.1B) $719.0M ($1.8B) Cash and equivalents at beginning of period $3.9B $3.9B $3.9B $5.1B Cash and equivalents at end of period $3.9B $2.8B $4.6B $3.3B Payments to Noncontrolling Interests $8.0M $4.0M $3.0M — Increase (decrease) in other investing items, net ($9.0M) $11.0M $7.0M — Proceeds from investments $27.0M — — $7.0M
Cardinal Health Inc. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.